Avita Drugs Sold to Long’s Drugs

We represented Avita Drugs Inc. in its sale to Long’s Drugs Inc., a portfolio company of Tailwind Capital.

Avita is a leading specialty pharmacy serving chronically ill patient populations in Louisiana, Texas, North Carolina, South Carolina and Virginia.

Long’s is a comprehensive pharmacy services provider in South Carolina, North Carolina and Georgia.

Tailwind Capital is a leading middle market private equity firm focused on growth-oriented investments in targeted sectors within healthcare, business and industrial services.

You Also May Be Interested In:

  • We served as Tennessee regulatory counsel for Caregiver, Inc., a provider of community-based services and support to more than three thousand individuals with intellectual and developmental disabilities across Texas, Tennessee, Indiana, and Ohio, in its recapitalization by WindRose Health Investors, LLC

    We served as Tennessee regulatory counsel for Caregiver, Inc., a provider of community-based services and support to more than three...
    Client Type: Private Company
  • Representation of Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, in its definitive agreement to sell certain assets of Passport Health Plan, including Passport’s brand, operational and clinical infrastructure, and certain provider and vendor agreements, to Molina Healthcare, Inc.

    We represented Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers...
    Client Type: Public Company
  • Representation of Forcura, LLC, a healthcare technology that facilitates continuity of care, in its sale to Accel-KKR, a Silicon Valley-based technology-focused private equity firm

    We represented Forcura, LLC, a healthcare technology that facilitates continuity of care, in its sale to Accel-KKR, a Silicon Valley-based...
    Client Type: Private Company